Duvelisib (IPI-145, INK1197)
99%
Reagent
Code: #100397
CAS Number
1201438-56-3
blur_circular Chemical Specifications
scatter_plot
Molecular Information
Weight
416.86 g/mol
Formula
C₂₂H₁₇ClN₆O
inventory_2
Storage & Handling
Storage
-20°C
description Product Description
Duvelisib is used in the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), as well as relapsed or refractory follicular lymphoma (FL) after at least two prior systemic therapies. It is a selective inhibitor of phosphoinositide 3-kinase (PI3K) delta and gamma isoforms, which play key roles in the growth and survival of malignant B-cells, thereby slowing disease progression. Duvelisib is also under investigation for other hematologic malignancies.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | Pale Yellow Solid |
| Purity (%) | 98.5-100% |
| Infrared Spectrum | Conforms To Structure |
shopping_cart Available Sizes & Pricing
Cart
No products
Subtotal:
0.00
Total
0.00
THB